The Ensign Group provided a range of skilled nursing and assisted living services as well as other post-acute healthcare services. The company does business in 13 US states in the South, West, and Mid-West regions. The slowing down of COVID in the US had led to a rise in the demand for healthcare services that Ensign offers. An aging US population is another long-term trend that boosts the future growth prospects of The Ensign Group.
The Long term monthly chart for Ensign shows a decade-long uptrend with prices doubling every two years till about 2014, followed by a period of sideways movement till 2018. Since then, the uptrend has gathered pace while the period from 2020 to mid-2021 has been one of the best. In those last 18 months, the price has risen 3X. The prices peaked at around $97 before pulling back 20% to find support at the $77 level. The reversal has led to the uptrend resuming again, and the likely target is now $97. A minimum stop loss can be placed below the support level and the bottom trend line at around $76.
Position entered into our long-term tracking portfolio today. The entry point is at $85.49, and stop-loss $76.06, which is 11% below the entry point. The short-term to medium-term take profit at the top of the trend is set at $94.88, giving a profit of 11%.
On the video and images above you will see the reason this stock was selected.
You will see the image is of a monthly chart of the stock showing the long-term upwards trend formed over the years. You will also see the entry point and the where the stop loss is placed. For more information please watch the video given.
Once it is time to move the original stop loss up you will see an additional image.
If you are interested in purchasing the above stock please click here to view some trading platforms.
Information is provided ‘as-is’ and solely for informational purposes. Data provided mostly by way of video and images are of actions that have already taken place and are not for trading purposes or advice.
Stock Prices End-of-Day. Information is provided solely for informational purposes, not for trading purposes or advice, and is delayed.